+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global POC Lipid Testing Market by Component (Instruments, Software), Indication (Cardiovascular Disease, Hypercholesterolemia, Hyperlipidaemia), End-User - Forecast 2024-2030- Product Image
Global POC Lipid Testing Market by Component (Instruments, Software), Indication (Cardiovascular Disease, Hypercholesterolemia, Hyperlipidaemia), End-User - Forecast 2024-2030- Product Image
Sale

Global POC Lipid Testing Market by Component (Instruments, Software), Indication (Cardiovascular Disease, Hypercholesterolemia, Hyperlipidaemia), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889599
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The POC Lipid Testing Market size was estimated at USD 315.41 million in 2023, USD 333.33 million in 2024, and is expected to grow at a CAGR of 6.18% to reach USD 480.15 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the POC Lipid Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the POC Lipid Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the POC Lipid Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc. by Zoetis Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Callegari Srl, Chembio Diagnostic Systems, Inc. by BIOSYNEX SA, Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., General Life Biotechnology Co., Ltd., Helena Laboratories Corporation, Menarini Group, Nova Biomedical, Quidel Corporation, SD Biosensor, Inc., Sekisui Medical Co., Ltd., Siemens AG, Sienco, Inc., Sinocare Inc., Thermo Fisher Scientific Inc., Trinity Biotech PLC, VivaChek Biotech (Hangzhou) Co., Ltd., and Werfen, S.A.

Market Segmentation & Coverage

This research report categorizes the POC Lipid Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Instruments
    • Software
  • Indication
    • Cardiovascular Disease
    • Hypercholesterolemia
    • Hyperlipidaemia
    • Tangier Disease
  • End-User
    • Diagnostic Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the POC Lipid Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the POC Lipid Testing Market?
  3. What are the technology trends and regulatory frameworks in the POC Lipid Testing Market?
  4. What is the market share of the leading vendors in the POC Lipid Testing Market?
  5. Which modes and strategic moves are suitable for entering the POC Lipid Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. POC Lipid Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in prevalence of cardiovascular disease across the globe
5.1.1.2. Rising investment on healthcare by private and public sector
5.1.2. Restraints
5.1.2.1. High cost associated with the production of POC lipid testing products
5.1.3. Opportunities
5.1.3.1. Ongoing innovation in medical industry for developing point of care lipid test products
5.1.3.2. Improving accessibility to healthcare and tests with rise in number of diagnostic centers
5.1.4. Challenges
5.1.4.1. Quality concerns associated with POC lipid testing
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. POC Lipid Testing Market, by Component
6.1. Introduction
6.2. Instruments
6.3. Software
7. POC Lipid Testing Market, by Indication
7.1. Introduction
7.2. Cardiovascular Disease
7.3. Hypercholesterolemia
7.4. Hyperlipidaemia
7.5. Tangier Disease
8. POC Lipid Testing Market, by End-User
8.1. Introduction
8.2. Diagnostic Centers
8.3. Hospitals & Clinics
9. Americas POC Lipid Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific POC Lipid Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa POC Lipid Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abaxis, Inc. by Zoetis Inc.
13.1.2. Abbott Laboratories
13.1.3. Bio-Rad Laboratories, Inc.
13.1.4. bioMérieux SA
13.1.5. Callegari Srl
13.1.6. Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
13.1.7. Danaher Corporation
13.1.8. EKF Diagnostics Holdings plc
13.1.9. F. Hoffmann-La Roche Ltd.
13.1.10. General Life Biotechnology Co., Ltd.
13.1.11. Helena Laboratories Corporation
13.1.12. Menarini Group
13.1.13. Nova Biomedical
13.1.14. Quidel Corporation
13.1.15. SD Biosensor, Inc.
13.1.16. Sekisui Medical Co., Ltd.
13.1.17. Siemens AG
13.1.18. Sienco, Inc.
13.1.19. Sinocare Inc.
13.1.20. Thermo Fisher Scientific Inc.
13.1.21. Trinity Biotech PLC
13.1.22. VivaChek Biotech (Hangzhou) Co., Ltd.
13.1.23. Werfen, S.A.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. POC LIPID TESTING MARKET RESEARCH PROCESS
FIGURE 2. POC LIPID TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. POC LIPID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. POC LIPID TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. POC LIPID TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. POC LIPID TESTING MARKET DYNAMICS
FIGURE 7. POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. POC LIPID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. POC LIPID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. POC LIPID TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. POC LIPID TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. POC LIPID TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. POC LIPID TESTING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. POC LIPID TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. POC LIPID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POC LIPID TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 6. POC LIPID TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. POC LIPID TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 9. POC LIPID TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. POC LIPID TESTING MARKET SIZE, BY HYPERCHOLESTEROLEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. POC LIPID TESTING MARKET SIZE, BY HYPERLIPIDAEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. POC LIPID TESTING MARKET SIZE, BY TANGIER DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 14. POC LIPID TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. POC LIPID TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. CANADA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 27. CANADA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. CANADA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. MEXICO POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 30. MEXICO POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. MEXICO POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. CHINA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 44. CHINA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. CHINA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. INDIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 47. INDIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. INDIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. JAPAN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 53. JAPAN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. JAPAN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. THAILAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 71. THAILAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. THAILAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. DENMARK POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 81. DENMARK POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. DENMARK POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. EGYPT POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 84. EGYPT POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. EGYPT POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. FINLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 87. FINLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. FINLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. FRANCE POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 90. FRANCE POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. FRANCE POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. GERMANY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 93. GERMANY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. ITALY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 99. ITALY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. ITALY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. NORWAY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 108. NORWAY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. NORWAY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. POLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 111. POLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. POLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. QATAR POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. QATAR POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. QATAR POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SPAIN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 126. SPAIN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SPAIN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. TURKEY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 135. TURKEY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. TURKEY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. POC LIPID TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 144. POC LIPID TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 145. POC LIPID TESTING MARKET LICENSE & PRICING

Companies Mentioned

  • Abaxis, Inc. by Zoetis Inc.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Callegari Srl
  • Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • General Life Biotechnology Co., Ltd.
  • Helena Laboratories Corporation
  • Menarini Group
  • Nova Biomedical
  • Quidel Corporation
  • SD Biosensor, Inc.
  • Sekisui Medical Co., Ltd.
  • Siemens AG
  • Sienco, Inc.
  • Sinocare Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • VivaChek Biotech (Hangzhou) Co., Ltd.
  • Werfen, S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 333.33 Million
Forecasted Market Value ( USD ) by 2030 $ 480.15 Million
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

POC Lipid Testing - Global Strategic Business Report - Product Image

POC Lipid Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Point of Care (PoC) Lipid Test Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Point of Care (PoC) Lipid Test Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Lipid Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Lipid Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 98 Pages
  • Global
From
Lipid Panel Testing Global Market Report 2024 - Product Image

Lipid Panel Testing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Cholesterol Testing: Global Strategic Business Report - Product Image

Cholesterol Testing: Global Strategic Business Report

  • Report
  • 273 Pages
  • Global
From

About the POC Lipid Test Market

The Point-of-Care (POC) Lipid Test market is a segment of the larger Point-of-Care Diagnostics industry. It is composed of medical devices and tests used to measure the levels of lipids, such as cholesterol and triglycerides, in a patient's blood. These tests are typically used to diagnose and monitor cardiovascular diseases, and are often performed in a doctor's office or at home. POC Lipid Tests are typically more convenient and cost-effective than traditional laboratory tests, and can provide results in minutes. The POC Lipid Test market is driven by the increasing prevalence of cardiovascular diseases, as well as the growing demand for convenient and cost-effective diagnostic solutions. The market is expected to continue to grow in the coming years, as more companies enter the space and develop innovative products. Some of the major players in the POC Lipid Test market include Abbott, Roche, Siemens, Alere, and Biosite. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.